Skip to content

Comparison of Anthropometric Parameters and Cardiometabolic Risk Factors Among Subjects With Overweight and Obesity

Comparison of Different Anthropometric Parameters in Relation to Cardiometabolic Risk Factors in a Cohort of Subjects With Overweight and Obesity

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04318288
Enrollment
1214
Registered
2020-03-23
Start date
2019-01-07
Completion date
2019-12-20
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

The study was aimed at comparing four different anthropometric parameters to cardiometabolic risk factors in overweight and obese subjects (Body Mass Index (BMI)≥25)

Detailed description

the present study was focused to compare the level of statistical association among four different anthropometric parameters, body mass index (BMI), waist circumference (WC), waist to height ratio (WHtR) and neck circumference (NC) and the cardiovascular (CV) risk factors most commonly evaluated in the clinical practice such as systolic and diastolic blood pressure, and fasting glucose, lipid (triglycerides, total, High-density lipoprotein (HDL) and Low-density lipoprotein (LDL) cholesterol), insulin, Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), uric acid, 25-hydroxyvitamin D (25(OH)D), c-reactive protein (CRP), white blood cells and platelet number in a population of 1214 apparently healthy subjects with overweight and obesity subjects

Interventions

OTHERObservational

Observational

Sponsors

Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Overweight or obesity (BMI\> 25 Kg/m2)

Exclusion criteria

* Any kind of drug * Hypertension * Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.), * Chronic inflammatory diseases * Renal failure * Liver failure * Angina pectoris * Myocardial infarction and heart failure * Genetic heart diseases * Thrombocytopenias

Design outcomes

Primary

MeasureTime frameDescription
Body mass indexbaselineBody mass index (BMI) (expressed in kg/m\^2)
waist circumferencebaselinewaist circumference (WC) (expressed in cm)
neck circumferencebaselineneck circumference (NC) (expressed in cm)
waist to height ratiobaselinewaist to height ratio (WHtR)

Secondary

MeasureTime frameDescription
fasting blood glucosebaselinefasting blood glucose (FBG) (expressed in mg/dL) concentration in serum
HDL CholesterolbaselineHDL Cholesterol (expressed in mg/dL) concentration in serum
InsulinbaselineInsulin (expressed in mg/dL) concentration in serum
Homeostasis model assessment: insulin resistancebaselineHomeostasis model assessment: insulin resistance index (HOMA-IR)
Intima-media thicknessbaselineIntima-media thickness (IMT) (expressed in mm)
PlateletsbaselinePlatelets (expressed in 10\^3/µL) concentration in serum
white blood cellsbaselinewhite blood cells (WBC) (expressed in 10\^3/µL) concentration in serum
Vitamin DbaselineVitamin D (expressed in ng/dL) concentration in serum
C-reactive ProteinbaselineC-reactive Protein (CRP) (expressed in mg/dL)
LDL CholesterolbaselineLDL Cholesterol (expressed in mg/dL) concentration in serum
Blood pressurebaselineblood pressure (BP) expressed in mmHg
Total CholesterolbaselineTotal Cholesterol (expressed in mg/dL) concentration in serum
TriglyceridebaselineTriglyceride (expressed in mg/dL) concentration in serum

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026